Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 1, 2026 | Cigna | Cardioverter-Defibrillator Devices | Metadata changed |
| Aug 1, 2026 | Cigna | Cardiac Omnibus Codes | Metadata changed |
| Aug 1, 2026 | Cigna | Blepharoplasty, Reconstructive Eyelid Surgery, and Brow Lift | Metadata changed |
| Aug 1, 2026 | Cigna | Bariatric Surgery and Procedures | Metadata changed |
| Aug 1, 2026 | Cigna | Autologous Platelet-Derived Growth Factors (Platelet-Rich Plasma [PRP]) | Metadata changed |
| Aug 1, 2026 | Cigna | Authorized Generics | Metadata changed |
| Aug 1, 2026 | Cigna | Athletic Pubalgia Surgery | Metadata changed |
| Aug 1, 2026 | Capital Blue Cross | Surgical Ventricular Restoration | Retired |
| Aug 1, 2026 | Capital Blue Cross | Mechanical Stretching Devices for Contracture and Joint Stiffness | Retired |
| Aug 1, 2026 | Capital Blue Cross | Vitamin D Testing | New policy |
| Aug 1, 2026 | Capital Blue Cross | Vitamin B12 and Methylmalonic Acid Testing | New policy |
| Aug 1, 2026 | Capital Blue Cross | Urine Culture Testing for Bacteria | New policy |
| Aug 1, 2026 | Capital Blue Cross | Urinary Tumor Markers for Bladder Cancer | New policy |
| Aug 1, 2026 | Capital Blue Cross | Thyroid Disease Testing | New policy |
| Aug 1, 2026 | Capital Blue Cross | Testosterone | New policy |
| Aug 1, 2026 | Capital Blue Cross | Testing for Vector-Borne Infections | New policy |
| Aug 1, 2026 | Capital Blue Cross | Testing for Diagnosis of Active or Latent Tuberculosis | New policy |
| Aug 1, 2026 | Capital Blue Cross | Serum Testing for Evidence of Mild Traumatic Brain Injury | New policy |
| Aug 1, 2026 | Capital Blue Cross | Salivary Hormone Testing | New policy |
| Aug 1, 2026 | Capital Blue Cross | Prostate Biopsy Specimen Analysis | New policy |
| Aug 1, 2026 | Capital Blue Cross | Prescription Medication and Illicit Drug Testing in the Outpatient Setting | New policy |
| Aug 1, 2026 | Capital Blue Cross | Prenatal Testing for Fetal Aneuploidy | New policy |
| Aug 1, 2026 | Capital Blue Cross | Pathogen Panel Testing | New policy |
| Aug 1, 2026 | Capital Blue Cross | Parathyroid Hormone, Phosphorus, Calcium, and Magnesium Testing | New policy |
| Aug 1, 2026 | Capital Blue Cross | Pancreatic Enzyme Testing for Acute Pancreatitis | New policy |
| Aug 1, 2026 | Capital Blue Cross | Oral Cancer Screening and Testing | New policy |
| Aug 1, 2026 | Capital Blue Cross | Onychomycosis Testing | New policy |
| Aug 1, 2026 | Capital Blue Cross | Nerve Fiber Density Testing | New policy |
| Aug 1, 2026 | Capital Blue Cross | Lyme Disease Testing | New policy |
| Aug 1, 2026 | Capital Blue Cross | In Vitro Chemoresistance and Chemosensitivity Assays | New policy |
| Aug 1, 2026 | Capital Blue Cross | Intracellular Micronutrient Analysis | New policy |
| Aug 1, 2026 | Capital Blue Cross | Immune Cell Function Assay | New policy |
| Aug 1, 2026 | Capital Blue Cross | Identification of Microorganisms using Nucleic Acid Probes | New policy |
| Aug 1, 2026 | Capital Blue Cross | Helicobacter pylori Testing | New policy |
| Aug 1, 2026 | Capital Blue Cross | General Inflammation Testing | New policy |
| Aug 1, 2026 | Capital Blue Cross | Gamma-glutamyl Transferase Testing in Adults | New policy |
| Aug 1, 2026 | Capital Blue Cross | Folate Testing | New policy |
| Aug 1, 2026 | Capital Blue Cross | Flow Cytometry | New policy |
| Aug 1, 2026 | Capital Blue Cross | Fecal Calprotectin Testing in Adults | New policy |
| Aug 1, 2026 | Capital Blue Cross | Fecal Analysis in the Diagnosis of Intestinal Dysbiosis and Fecal Microbiota Transplant Testing | New policy |
| Aug 1, 2026 | Capital Blue Cross | Evaluation of Dry Eyes | New policy |
| Aug 1, 2026 | Capital Blue Cross | Epithelial Cell Cytology in Breast Cancer Risk Assessment | New policy |
| Aug 1, 2026 | Capital Blue Cross | Diagnostic Testing of Iron Homeostasis and Metabolism | New policy |
| Aug 1, 2026 | Capital Blue Cross | Diagnostic Testing of Influenza | New policy |
| Aug 1, 2026 | Capital Blue Cross | Diagnosis of Vaginitis | New policy |
| Aug 1, 2026 | Capital Blue Cross | Diagnosis of Idiopathic Environmental Intolerance | New policy |
| Aug 1, 2026 | Capital Blue Cross | Diabetes Mellitus Testing | New policy |
| Aug 1, 2026 | Capital Blue Cross | Coronavirus Testing in the Outpatient Setting | New policy |
| Aug 1, 2026 | Capital Blue Cross | Celiac Disease Testing | New policy |
| Aug 1, 2026 | Capital Blue Cross | Cardiovascular Disease Risk Assessment | New policy |